Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Soho Global Health TbkISX:SOHO +0.42%87 Piotroski F-Score is 8 as of Sep. 06, 2026, which is 33% above its 10-year median of 6.00. GuruFocus rates ISX:SOHO with a GF Score™ of 87/100 and a GF Value™ of Rp805.04 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 116 Medical Distribution companies, PT Soho Global Health Tbk ranks better than 98.28% on this metric.
Good Sign:
Piotroski F-Score is 8, indicates a very healthy situation.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
PT Soho Global Health Tbk has an F-score of 8. It is a good or high score, which usually indicates a very healthy situation.
The historical rank and industry rank for PT Soho Global Health Tbk's Piotroski F-Score or its related term are showing as below:
ISX:SOHO'
s Piotroski F-Score Range Over the Past 10 Years
Min: 4 Med: 6 Max: 8
Current: 8
During the past 7 years, the highest Piotroski F-Score of PT Soho Global Health Tbk was 8. The lowest was 4. And the median was 6.
PT Soho Global Health Tbk (ISX:SOHO) Piotroski F-Score Explanation
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
PT Soho Global Health Tbk Piotroski F-Score Related Terms
PT Soho Global Health Tbk Piotroski F-Score Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISX:SOHO vs MCK, COR, CAH: Piotroski F-Score Comparison
For the Medical Distribution subindustry, PT Soho Global Health Tbk's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Soho Global Health Tbk Piotroski F-Score vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, PT Soho Global Health Tbk's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where PT Soho Global Health Tbk's Piotroski F-Score falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
This Year (Jun26) TTM:
Last Year (Jun25) TTM:
Net Income was 149733 + 160228 + 189858 + 183064 = Rp682,883 Mil. Cash Flow from Operations was 277346 + 194337 + 143763 + 324210 = Rp939,656 Mil. Revenue was 2755513 + 2854681 + 2635637 + 2726781 = Rp10,972,612 Mil. Gross Profit was 448110 + 495354 + 532294 + 539327 = Rp2,015,085 Mil.
Average Total Assets from the begining of this year (Jun25)
to the end of this year (Jun26) was
(5477568 + 6005153 + 6157487 + 5797181 + 5594308) / 5 = Rp5806339.4 Mil. Total Assets at the begining of this year (Jun25) was Rp5,477,568 Mil. Long-Term Debt & Capital Lease Obligation was Rp2,631 Mil. Total Current Assets was Rp4,966,088 Mil. Total Current Liabilities was Rp2,936,269 Mil.
Net Income was 115858 + 121204 + 133245 + 157115 = Rp527,422 Mil.
Revenue was 2589575 + 2587244 + 2670918 + 2498075 = Rp10,345,812 Mil. Gross Profit was 388010 + 386536 + 449927 + 411045 = Rp1,635,518 Mil.
Average Total Assets from the begining of last year (Jun24)
to the end of last year (Jun25) was
(5310206 + 5243408 + 5412023 + 5500246 + 5477568) / 5 = Rp5388690.2 Mil. Total Assets at the begining of last year (Jun24) was Rp5,310,206 Mil. Long-Term Debt & Capital Lease Obligation was Rp4,179 Mil. Total Current Assets was Rp4,815,847 Mil. Total Current Liabilities was Rp2,591,223 Mil.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
PT Soho Global Health Tbk's current Net Income (TTM) was 682,883.
==> Positive ==> Score 1.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
PT Soho Global Health Tbk's current Cash Flow from Operations (TTM) was 939,656.
==> Positive ==> Score 1.
Question 3. Change in Return on Assets
Compare this year's return on assets (1) to last year's return on assets.
PT Soho Global Health Tbk's return on assets of this year was 0.12466901. PT Soho Global Health Tbk's return on assets of last year was 0.09932232.
==> This year is higher. ==> Score 1.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
PT Soho Global Health Tbk's gearing of this year was 0.00045313. PT Soho Global Health Tbk's gearing of last year was 0.00077551.
==> This year is lower or equal to last year. ==> Score 1.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
PT Soho Global Health Tbk's current ratio of this year was 1.69129191. PT Soho Global Health Tbk's current ratio of last year was 1.85852279.
==> Last year's current ratio is higher ==> Score 0.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
PT Soho Global Health Tbk's number of shares in issue this year was 12691.682. PT Soho Global Health Tbk's number of shares in issue last year was 12691.682.
==> There is smaller number of shares in issue this year, or the same. ==> Score 1.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
PT Soho Global Health Tbk's gross margin of this year was 0.18364679. PT Soho Global Health Tbk's gross margin of last year was 0.15808503.
==> This year's gross margin is higher. ==> Score 1.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
PT Soho Global Health Tbk's asset turnover of this year was 2.00319047. PT Soho Global Health Tbk's asset turnover of last year was 1.94828826.
==> This year's asset turnover is higher. ==> Score 1.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
1
+
1
+
1
+
1
+
1
+
0
+
1
+
1
+
1
=
8
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
PT Soho Global Health Tbk has an F-score of 8. It is a good or high score, which usually indicates a very healthy situation.
PT Soho Global Health Tbk (ISX:SOHO) has a Piotroski F-Score of 8 as of Sep. 06, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on PT Soho Global Health Tbk and its competitors. This is 33% above median its historical median of 6.00. Over the past decade, PT Soho Global Health Tbk's Piotroski F-Score has ranged from 4.00 to 8.00. According to the industry distribution chart, PT Soho Global Health Tbk ranks #2 out of 116 companies in the Medical Distribution industry, placing it in the top 1.7%.
Is PT Soho Global Health Tbk's Piotroski F-Score too high?
PT Soho Global Health Tbk's current Piotroski F-Score of 8 is 33% above median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 8.00. The Medical Distribution industry median Piotroski F-Score is 5.00. PT Soho Global Health Tbk's value of 8 is 60% above this industry median. Based on the distribution chart, PT Soho Global Health Tbk ranks #2 out of 116 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, PT Soho Global Health Tbk has a GF Score™ of 87/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PT Soho Global Health Tbk's Piotroski F-Score compare to MCK and COR?
According to the Medical Distribution industry distribution chart, PT Soho Global Health Tbk ranks #2 out of 116 companies for Piotroski F-Score. This places PT Soho Global Health Tbk in the top 2% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. PT Soho Global Health Tbk's value of 8 is 60% above this benchmark. Historically, PT Soho Global Health Tbk's own Piotroski F-Score has ranged from 4.00 to 8.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, PT Soho Global Health Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Distribution company?
The median Piotroski F-Score among Medical Distribution companies is 5.00, based on 116 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Soho Global Health Tbk's current Piotroski F-Score of 8 is 60% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on PT Soho Global Health Tbk and its competitors. For the Medical Distribution industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Soho Global Health Tbk's current Piotroski F-Score is 8, which is 33% above median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Soho Global Health Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Soho Global Health Tbk (ISX:SOHO) is currently considered Significantly Overvalued. The stock's GF Value™ is Rp805.04, compared to a current price of Rp1,205.00 — trading 49.7% above its estimated fair value. The current Piotroski F-Score is 8, which is 33% above median its 10-year median of 6.00 and 60% above the Medical Distribution industry median of 5.00. PT Soho Global Health Tbk's overall GF Score™ is 87/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For PT Soho Global Health Tbk (ISX:SOHO), the current Piotroski F-Score is 8 as of Sep. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Soho Global Health Tbk (ISX:SOHO) Overvalued in 2026?
Based on GuruFocus' analysis, PT Soho Global Health Tbk stock appears to be overvalued.
The current stock price of Rp1,205.00 is trading 49.7% above its estimated GF Value™ of Rp805.04.
GuruFocus considers PT Soho Global Health Tbk to be Significantly Overvalued.
Key valuation signals for ISX:SOHO:
Piotroski F-Score: 8 (33% above median its 10-year median of 6.00)
GF Value™: Rp805.04 vs. price of Rp1,205.00 (49.7% above fair value)
Industry Position: 60% above the Medical Distribution median (#2 of 116)
No single metric tells the full story. See the ISX:SOHO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Soho Global Health Tbk is a healthcare company operating in the areas of natural/herbal health care products and services. The company manufactures and distributes pharmaceutical products, including herbal cures, proprietary medicines, and health foods, under various brand names such as Curcuma Plus, Curcuma Plus Milk; Imboost; Fitkom; Diapet; Laxing; Lelap; Asthma Soho, and Sohobion. Its segment includes Distribution, Consumer health, Alliance, and others. The company generates maximum revenue from the Distribution segment.
87GF Score
Get the complete analysis for ISX:SOHO
Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:SOHO has been successfully added to your 
